Do analysts prefer LUCY or POAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Predictive Oncology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer LUCY or POAI?

In the previous week, Innovative Eyewear had 1 more articles in the media than Predictive Oncology. MarketBeat recorded 2 mentions for Innovative Eyewear and 1 mentions for Predictive Oncology. Innovative Eyewear's average media sentiment score of 0.60 beat Predictive Oncology's score of 0.00 indicating that Innovative Eyewear is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Predictive Oncology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer LUCY or FEMY?

Femasys has a consensus price target of $5.33, indicating a potential upside of 1,385.61%. Given Femasys' stronger consensus rating and higher possible upside, analysts clearly believe Femasys is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Femasys 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Is LUCY or FEMY more profitable?

Innovative Eyewear has a net margin of -272.42% compared to Femasys' net margin of -521.97%. Innovative Eyewear's return on equity of -83.37% beat Femasys' return on equity. Company Net Margins Return on Equity Return on Assets Innovative Eyewear -272.42% -83.37% -76.02% Femasys -521.97% -258.08% -73.72%

Does the media prefer LUCY or FEMY?

In the previous week, Innovative Eyewear had 1 more articles in the media than Femasys. MarketBeat recorded 2 mentions for Innovative Eyewear and 1 mentions for Femasys. Femasys' average media sentiment score of 1.87 beat Innovative Eyewear's score of 0.60 indicating that Femasys is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Femasys 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts prefer TMDIF or LUCY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media favor TMDIF or LUCY?

In the previous week, Innovative Eyewear had 1 more articles in the media than Titan Medical. MarketBeat recorded 2 mentions for Innovative Eyewear and 1 mentions for Titan Medical. Innovative Eyewear's average media sentiment score of 0.60 beat Titan Medical's score of 0.00 indicating that Innovative Eyewear is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Titan Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend MODD or LUCY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to MODD or LUCY?

In the previous week, Innovative Eyewear had 1 more articles in the media than Modular Medical. MarketBeat recorded 2 mentions for Innovative Eyewear and 1 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.65 beat Innovative Eyewear's score of 0.60 indicating that Modular Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Modular Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer LUCY or RVP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Innovative Eyewear (LUCY) Competitors

$0.96 -0.01 (-0.52%)

As of 12:57 PM Eastern

Compare

LUCY vs. POAI, FEMY, TMDIF, MODD, and RVP

Should you buy Innovative Eyewear stock or one of its competitors? MarketBeat compares Innovative Eyewear with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Innovative Eyewear include Predictive Oncology (POAI), Femasys (FEMY), Titan Medical (TMDIF), Modular Medical (MODD), and Retractable Technologies (RVP). These companies are all part of the "medical equipment" industry.

How does Innovative Eyewear compare to Predictive Oncology?

Innovative Eyewear (NASDAQ:LUCY) and Predictive Oncology (NASDAQ:POAI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Innovative Eyewear has higher revenue and earnings than Predictive Oncology. Predictive Oncology is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Eyewear	$2.66M	2.30	-$7.59M	-$1.69	N/A
Predictive Oncology	$1.66M	16.58	-$12.66M	-$13.50	N/A

In the previous week, Innovative Eyewear had 1 more articles in the media than Predictive Oncology. MarketBeat recorded 2 mentions for Innovative Eyewear and 1 mentions for Predictive Oncology. Innovative Eyewear's average media sentiment score of 0.60 beat Predictive Oncology's score of 0.00 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Innovative Eyewear	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Predictive Oncology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are owned by institutional investors. 1.7% of Innovative Eyewear shares are owned by insiders. Comparatively, 1.2% of Predictive Oncology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Innovative Eyewear has a net margin of -272.42% compared to Predictive Oncology's net margin of -5,065.23%. Innovative Eyewear's return on equity of -83.37% beat Predictive Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innovative Eyewear	-272.42%	-83.37%	-76.02%
Predictive Oncology	-5,065.23%	-732.73%	-235.55%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Innovative Eyewear has a beta of 2.66, suggesting that its stock price is 166% more volatile than the broader market. Comparatively, Predictive Oncology has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market.

Summary

Innovative Eyewear beats Predictive Oncology on 12 of the 14 factors compared between the two stocks.

How does Innovative Eyewear compare to Femasys?

Innovative Eyewear (NASDAQ:LUCY) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

Innovative Eyewear has a net margin of -272.42% compared to Femasys' net margin of -521.97%. Innovative Eyewear's return on equity of -83.37% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innovative Eyewear	-272.42%	-83.37%	-76.02%
Femasys	-521.97%	-258.08%	-73.72%

Innovative Eyewear has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Eyewear	$2.66M	2.30	-$7.59M	-$1.69	N/A
Femasys	$2.29M	9.47	-$18.63M	-$0.27	N/A

In the previous week, Innovative Eyewear had 1 more articles in the media than Femasys. MarketBeat recorded 2 mentions for Innovative Eyewear and 1 mentions for Femasys. Femasys' average media sentiment score of 1.87 beat Innovative Eyewear's score of 0.60 indicating that Femasys is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Innovative Eyewear	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Femasys	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 65.3% of Femasys shares are owned by institutional investors. 1.7% of Innovative Eyewear shares are owned by company insiders. Comparatively, 7.6% of Femasys shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Innovative Eyewear has a beta of 2.66, suggesting that its share price is 166% more volatile than the broader market. Comparatively, Femasys has a beta of -2.23, suggesting that its share price is 323% less volatile than the broader market.

Femasys has a consensus price target of $5.33, indicating a potential upside of 1,385.61%. Given Femasys' stronger consensus rating and higher possible upside, analysts clearly believe Femasys is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Femasys beats Innovative Eyewear on 9 of the 16 factors compared between the two stocks.

How does Innovative Eyewear compare to Titan Medical?

Titan Medical (NASDAQ:TMDIF) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

Titan Medical has a net margin of 0.00% compared to Innovative Eyewear's net margin of -272.42%. Titan Medical's return on equity of -82.31% beat Innovative Eyewear's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Innovative Eyewear	-272.42%	-83.37%	-76.02%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by insiders. Comparatively, 1.7% of Innovative Eyewear shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.66, suggesting that its stock price is 166% more volatile than the broader market.

In the previous week, Innovative Eyewear had 1 more articles in the media than Titan Medical. MarketBeat recorded 2 mentions for Innovative Eyewear and 1 mentions for Titan Medical. Innovative Eyewear's average media sentiment score of 0.60 beat Titan Medical's score of 0.00 indicating that Innovative Eyewear is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Titan Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Innovative Eyewear	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Titan Medical has higher revenue and earnings than Innovative Eyewear. Innovative Eyewear is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	1.23	$6.95M	$0.05	3.80
Innovative Eyewear	$2.66M	2.30	-$7.59M	-$1.69	N/A

Summary

Titan Medical and Innovative Eyewear tied by winning 7 of the 14 factors compared between the two stocks.

How does Innovative Eyewear compare to Modular Medical?

Modular Medical (NASDAQ:MODD) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

27.5% of Modular Medical shares are held by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are held by institutional investors. 7.1% of Modular Medical shares are held by company insiders. Comparatively, 1.7% of Innovative Eyewear shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Modular Medical has a net margin of 0.00% compared to Innovative Eyewear's net margin of -272.42%. Innovative Eyewear's return on equity of -83.37% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-245.85%	-190.80%
Innovative Eyewear	-272.42%	-83.37%	-76.02%

Innovative Eyewear has higher revenue and earnings than Modular Medical. Innovative Eyewear is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$18.82M	-$14.71	N/A
Innovative Eyewear	$2.66M	2.30	-$7.59M	-$1.69	N/A

In the previous week, Innovative Eyewear had 1 more articles in the media than Modular Medical. MarketBeat recorded 2 mentions for Innovative Eyewear and 1 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.65 beat Innovative Eyewear's score of 0.60 indicating that Modular Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Modular Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Innovative Eyewear	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Modular Medical has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.66, suggesting that its stock price is 166% more volatile than the broader market.

Summary

Innovative Eyewear beats Modular Medical on 8 of the 13 factors compared between the two stocks.

How does Innovative Eyewear compare to Retractable Technologies?

Innovative Eyewear (NASDAQ:LUCY) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations.

In the previous week, Innovative Eyewear had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for Innovative Eyewear and 0 mentions for Retractable Technologies. Innovative Eyewear's average media sentiment score of 0.60 beat Retractable Technologies' score of 0.00 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company	Overall Sentiment
Innovative Eyewear	Positive
Retractable Technologies	Neutral

Innovative Eyewear has a beta of 2.66, indicating that its share price is 166% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.25, indicating that its share price is 25% more volatile than the broader market.

Retractable Technologies has a net margin of -41.11% compared to Innovative Eyewear's net margin of -272.42%. Retractable Technologies' return on equity of -17.15% beat Innovative Eyewear's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innovative Eyewear	-272.42%	-83.37%	-76.02%
Retractable Technologies	-41.11%	-17.15%	-9.33%

Retractable Technologies has higher revenue and earnings than Innovative Eyewear. Retractable Technologies is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Eyewear	$2.66M	2.30	-$7.59M	-$1.69	N/A
Retractable Technologies	$37.15M	0.53	-$7.01M	-$0.21	N/A

1.0% of Innovative Eyewear shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 1.7% of Innovative Eyewear shares are held by insiders. Comparatively, 59.5% of Retractable Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Retractable Technologies beats Innovative Eyewear on 8 of the 14 factors compared between the two stocks.

Get Innovative Eyewear News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LUCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LUCY vs. The Competition

Export

Metric	Innovative Eyewear	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$6.11M	$8.22B	$6.45B	$12.42B
Dividend Yield	N/A	2.61%	2.69%	5.22%
P/E Ratio	-0.57	15.74	23.89	24.35
Price / Sales	2.30	7.14	524.38	119.30
Price / Cash	N/A	17.10	41.27	57.13
Price / Book	0.57	3.64	10.06	6.74
Net Income	-$7.59M	$224.05M	$3.56B	$337.03M
7 Day Performance	-8.17%	-0.23%	-0.60%	0.24%
1 Month Performance	N/A	N/A	N/A	-1.60%
1 Year Performance	-69.19%	2.77%	29.29%	34.04%

Innovative Eyewear Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LUCY Innovative Eyewear	0.735 of 5 stars	$0.96 -0.5%	N/A	-69.2%	$6.11M	$2.66M	N/A	9	News Coverage Analyst Downgrade Short Interest Increase
POAI Predictive Oncology	0.0245 of 5 stars	$6.92 +29.6%	N/A	-41.1%	$23.49M	$1.66M	N/A	30	News Coverage High Trading Volume
FEMY Femasys	2.4461 of 5 stars	$0.38 -8.0%	$5.33 +1,314.7%	-54.0%	$22.77M	$2.29M	N/A	30	Positive News Gap Down High Trading Volume
TMDIF Titan Medical	N/A	$0.20 -3.9%	N/A	-30.1%	$22.35M	$17.63M	N/A	50	News Coverage Gap Down
MODD Modular Medical	0.2883 of 5 stars	$4.73 -3.4%	N/A	-82.5%	$21.88M	N/A	N/A	20	News Coverage Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LUCY) was last updated on 6/4/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Innovative Eyewear (LUCY) Competitors

LUCY vs. POAI, FEMY, TMDIF, MODD, and RVP

How does Innovative Eyewear compare to Predictive Oncology?

Summary

How does Innovative Eyewear compare to Femasys?

Summary

How does Innovative Eyewear compare to Titan Medical?

Summary

How does Innovative Eyewear compare to Modular Medical?

Summary

How does Innovative Eyewear compare to Retractable Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LUCY vs. The Competition

Innovative Eyewear Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Innovative Eyewear (LUCY) Competitors

LUCY vs. POAI, FEMY, TMDIF, MODD, and RVP

How does Innovative Eyewear compare to Predictive Oncology?

Which has preferable valuation and earnings, LUCY or POAI?

Does the media prefer LUCY or POAI?

Do institutionals & insiders believe in LUCY or POAI?

Is LUCY or POAI more profitable?

Do analysts prefer LUCY or POAI?

Which has more risk & volatility, LUCY or POAI?

Summary

How does Innovative Eyewear compare to Femasys?

Is LUCY or FEMY more profitable?

Which has better valuation & earnings, LUCY or FEMY?

Does the media prefer LUCY or FEMY?

Do insiders and institutionals believe in LUCY or FEMY?

Which has more volatility and risk, LUCY or FEMY?

Do analysts prefer LUCY or FEMY?

Summary

How does Innovative Eyewear compare to Titan Medical?

Is TMDIF or LUCY more profitable?

Do analysts prefer TMDIF or LUCY?

Do insiders & institutionals believe in TMDIF or LUCY?

Which has more risk & volatility, TMDIF or LUCY?

Does the media favor TMDIF or LUCY?

Which has higher earnings and valuation, TMDIF or LUCY?

Summary

How does Innovative Eyewear compare to Modular Medical?

Do institutionals and insiders have more ownership in MODD or LUCY?

Do analysts recommend MODD or LUCY?

Is MODD or LUCY more profitable?

Which has stronger earnings and valuation, MODD or LUCY?

Does the media refer more to MODD or LUCY?

Which has more volatility and risk, MODD or LUCY?

Summary

How does Innovative Eyewear compare to Retractable Technologies?

Does the media refer more to LUCY or RVP?

Which has more risk and volatility, LUCY or RVP?

Is LUCY or RVP more profitable?

Which has higher valuation and earnings, LUCY or RVP?

Do insiders and institutionals hold more shares of LUCY or RVP?

Do analysts prefer LUCY or RVP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LUCY vs. The Competition

Innovative Eyewear Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools